ORION BIOSCIENCE INC. is a preclinical stage Nebraska biotechnology company focused on developing our Soluble Antigen Array (SAgA) platform for the interception and reversal of autoimmune diseases like Type-1 diabtes and neuromyelitis optica. Orion's SAgAs work by mimicking peripheral tolerance to restore health.